HCS PHARMA

HCS Pharma is a biotechnology company focused on in vitro R&D, specializing in High Content Analysis (HCA) and High Content Screening (HCS), namely automated cell imaging. HCS Pharma sells 3D cell culture products based on BIOMIMESYS® technology, and develops its own 3D cellular models in its proprietary BIOMIMESYS® extracellular matrix. BIOMIMESYS® 3D culture technology faithfully reproduces the natural microenvironment of cells in 3D, to ensure more predictive results from in vitro studies, to reduce the time and cost of R&D, and animal testing in pharmaceutical, nutraceutical and cosmetic companies... We develop our own models that we offer for services in different fields (Toxicology, Pharmacology, Dermocosmetic), our own compound libraries (Prestwick, ENZO, ELF…), and our own innovative and exclusive 3D technology BIOMIMESYS® biofunctionalized scaffold for innovative phenotypic screening model.

Primary location: Loos France